ポイントオブケア(POC)/迅速診断の世界市場2023年:迅速検査、分子診断

■ 英語タイトル:Global Point of Care & Rapid Diagnostics Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート(データ管理コード:QYR23MA7530)■ 発行会社/調査会社:QYResearch
■ 商品コード:QYR23MA7530
■ 発行日:2023年3月
■ 調査対象地域:グローバル
■ 産業分野:医療
■ ページ数:96
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(受注後2-3営業日)
■ 販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,900 ⇒換算¥440,800見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD4,350 ⇒換算¥661,200見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD5,800 ⇒換算¥881,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[ポイントオブケア(POC)/迅速診断の世界市場2023年:迅速検査、分子診断]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

当調査資料はポイントオブケア(POC)/迅速診断のグローバル市場について調査・分析し、世界のポイントオブケア(POC)/迅速診断市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析(迅速検査、分子診断)、用途別セグメント分析(病院、在宅医療)、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Johnson and Johnson、Thermo Fisher Scientific、Bio-Techne、Roche Diagnostics、Siemens Healthineers、Abbott Laboratories、Danaher Corporation、BD、Sysmex、Cardinal Health、Quidel、GE Healthcare、EKF Diagnostics、bioMérieux SA、Accubiotech、PTS Diagnostics、Chembio Diagnostics、Trinity Biotech、Sekisui Diagnosticsなどが含まれています。ポイントオブケア(POC)/迅速診断のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX%です。新型コロナとロシア・ウクライナ戦争の影響は、ポイントオブケア(POC)/迅速診断市場規模を算出する際に考慮しました。

・ポイントオブケア(POC)/迅速診断市場の概要
- ポイントオブケア(POC)/迅速診断の種類別セグメント
- 世界のポイントオブケア(POC)/迅速診断市場規模:タイプ別分析(迅速検査、分子診断)
- ポイントオブケア(POC)/迅速診断の用途別セグメント
- 世界のポイントオブケア(POC)/迅速診断市場規模:用途別分析(病院、在宅医療)
- 世界のポイントオブケア(POC)/迅速診断市場規模予測(2018年-2029年)

・ポイントオブケア(POC)/迅速診断市場の成長トレンド
- ポイントオブケア(POC)/迅速診断の地域別市場規模(2018年-2029年)
- ポイントオブケア(POC)/迅速診断市場ダイナミクス
- ポイントオブケア(POC)/迅速診断の業界動向
- ポイントオブケア(POC)/迅速診断市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M&A動向

・種類別セグメント:迅速検査、分子診断
- 世界のポイントオブケア(POC)/迅速診断のタイプ別市場規模(2018年-2023年)
- 世界のポイントオブケア(POC)/迅速診断のタイプ別市場規模(2024年-2029年)

・用途別セグメント:病院、在宅医療
- 世界のポイントオブケア(POC)/迅速診断の用途別市場規模(2018年-2023年)
- 世界のポイントオブケア(POC)/迅速診断の用途別市場規模(2024年-2029年)

・ポイントオブケア(POC)/迅速診断の地域別市場規模
- 北米のポイントオブケア(POC)/迅速診断市場規模(2018年-2029年)
- 米国のポイントオブケア(POC)/迅速診断市場規模(2018年-2029年)
- ヨーロッパのポイントオブケア(POC)/迅速診断市場規模(2018年-2029年)
- アジア太平洋のポイントオブケア(POC)/迅速診断市場規模(2018年-2029年)
- 中国のポイントオブケア(POC)/迅速診断市場規模(2018年-2029年)
- 日本のポイントオブケア(POC)/迅速診断市場規模(2018年-2029年)
- 韓国のポイントオブケア(POC)/迅速診断市場規模(2018年-2029年)
- インドのポイントオブケア(POC)/迅速診断市場規模(2018年-2029年)
- オーストラリアのポイントオブケア(POC)/迅速診断市場規模(2018年-2029年)
- 中南米のポイントオブケア(POC)/迅速診断市場規模(2018年-2029年)
- 中東・アフリカのポイントオブケア(POC)/迅速診断市場規模(2018年-2029年)

・主要企業のプロファイル:企業情報、事業概要、売上、動向
Johnson and Johnson、Thermo Fisher Scientific、Bio-Techne、Roche Diagnostics、Siemens Healthineers、Abbott Laboratories、Danaher Corporation、BD、Sysmex、Cardinal Health、Quidel、GE Healthcare、EKF Diagnostics、bioMérieux SA、Accubiotech、PTS Diagnostics、Chembio Diagnostics、Trinity Biotech、Sekisui Diagnostics

・アナリストの観点/結論

・調査手法と情報源

Highlights
The global Point of Care & Rapid Diagnostics market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Point of Care & Rapid Diagnostics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Point of Care & Rapid Diagnostics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Point of Care & Rapid Diagnostics in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Point of Care & Rapid Diagnostics include Johnson and Johnson, Thermo Fisher Scientific, Bio-Techne, Roche Diagnostics, Siemens Healthineers, Abbott Laboratories, Danaher Corporation, BD and Sysmex, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Point of Care & Rapid Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Point of Care & Rapid Diagnostics.
The Point of Care & Rapid Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Point of Care & Rapid Diagnostics market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Point of Care & Rapid Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Johnson and Johnson
Thermo Fisher Scientific
Bio-Techne
Roche Diagnostics
Siemens Healthineers
Abbott Laboratories
Danaher Corporation
BD
Sysmex
Cardinal Health
Quidel
GE Healthcare
EKF Diagnostics
bioMérieux SA
Accubiotech
PTS Diagnostics
Chembio Diagnostics
Trinity Biotech
Sekisui Diagnostics
Segment by Type
Rapid Test
Molecular Diagnostics
Segment by Application
Hospital
Home Care
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Point of Care & Rapid Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

*** レポート目次(コンテンツ)***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Point of Care & Rapid Diagnostics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Rapid Test
1.2.3 Molecular Diagnostics
1.3 Market by Application
1.3.1 Global Point of Care & Rapid Diagnostics Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Home Care
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Point of Care & Rapid Diagnostics Market Perspective (2018-2029)
2.2 Point of Care & Rapid Diagnostics Growth Trends by Region
2.2.1 Global Point of Care & Rapid Diagnostics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Point of Care & Rapid Diagnostics Historic Market Size by Region (2018-2023)
2.2.3 Point of Care & Rapid Diagnostics Forecasted Market Size by Region (2024-2029)
2.3 Point of Care & Rapid Diagnostics Market Dynamics
2.3.1 Point of Care & Rapid Diagnostics Industry Trends
2.3.2 Point of Care & Rapid Diagnostics Market Drivers
2.3.3 Point of Care & Rapid Diagnostics Market Challenges
2.3.4 Point of Care & Rapid Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Point of Care & Rapid Diagnostics Players by Revenue
3.1.1 Global Top Point of Care & Rapid Diagnostics Players by Revenue (2018-2023)
3.1.2 Global Point of Care & Rapid Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global Point of Care & Rapid Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Point of Care & Rapid Diagnostics Revenue
3.4 Global Point of Care & Rapid Diagnostics Market Concentration Ratio
3.4.1 Global Point of Care & Rapid Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Point of Care & Rapid Diagnostics Revenue in 2022
3.5 Point of Care & Rapid Diagnostics Key Players Head office and Area Served
3.6 Key Players Point of Care & Rapid Diagnostics Product Solution and Service
3.7 Date of Enter into Point of Care & Rapid Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Point of Care & Rapid Diagnostics Breakdown Data by Type
4.1 Global Point of Care & Rapid Diagnostics Historic Market Size by Type (2018-2023)
4.2 Global Point of Care & Rapid Diagnostics Forecasted Market Size by Type (2024-2029)
5 Point of Care & Rapid Diagnostics Breakdown Data by Application
5.1 Global Point of Care & Rapid Diagnostics Historic Market Size by Application (2018-2023)
5.2 Global Point of Care & Rapid Diagnostics Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Point of Care & Rapid Diagnostics Market Size (2018-2029)
6.2 North America Point of Care & Rapid Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Point of Care & Rapid Diagnostics Market Size by Country (2018-2023)
6.4 North America Point of Care & Rapid Diagnostics Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Point of Care & Rapid Diagnostics Market Size (2018-2029)
7.2 Europe Point of Care & Rapid Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Point of Care & Rapid Diagnostics Market Size by Country (2018-2023)
7.4 Europe Point of Care & Rapid Diagnostics Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Point of Care & Rapid Diagnostics Market Size (2018-2029)
8.2 Asia-Pacific Point of Care & Rapid Diagnostics Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Point of Care & Rapid Diagnostics Market Size by Region (2018-2023)
8.4 Asia-Pacific Point of Care & Rapid Diagnostics Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Point of Care & Rapid Diagnostics Market Size (2018-2029)
9.2 Latin America Point of Care & Rapid Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Point of Care & Rapid Diagnostics Market Size by Country (2018-2023)
9.4 Latin America Point of Care & Rapid Diagnostics Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Point of Care & Rapid Diagnostics Market Size (2018-2029)
10.2 Middle East & Africa Point of Care & Rapid Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Point of Care & Rapid Diagnostics Market Size by Country (2018-2023)
10.4 Middle East & Africa Point of Care & Rapid Diagnostics Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson and Johnson
11.1.1 Johnson and Johnson Company Detail
11.1.2 Johnson and Johnson Business Overview
11.1.3 Johnson and Johnson Point of Care & Rapid Diagnostics Introduction
11.1.4 Johnson and Johnson Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.1.5 Johnson and Johnson Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Point of Care & Rapid Diagnostics Introduction
11.2.4 Thermo Fisher Scientific Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Bio-Techne
11.3.1 Bio-Techne Company Detail
11.3.2 Bio-Techne Business Overview
11.3.3 Bio-Techne Point of Care & Rapid Diagnostics Introduction
11.3.4 Bio-Techne Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.3.5 Bio-Techne Recent Development
11.4 Roche Diagnostics
11.4.1 Roche Diagnostics Company Detail
11.4.2 Roche Diagnostics Business Overview
11.4.3 Roche Diagnostics Point of Care & Rapid Diagnostics Introduction
11.4.4 Roche Diagnostics Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.4.5 Roche Diagnostics Recent Development
11.5 Siemens Healthineers
11.5.1 Siemens Healthineers Company Detail
11.5.2 Siemens Healthineers Business Overview
11.5.3 Siemens Healthineers Point of Care & Rapid Diagnostics Introduction
11.5.4 Siemens Healthineers Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.5.5 Siemens Healthineers Recent Development
11.6 Abbott Laboratories
11.6.1 Abbott Laboratories Company Detail
11.6.2 Abbott Laboratories Business Overview
11.6.3 Abbott Laboratories Point of Care & Rapid Diagnostics Introduction
11.6.4 Abbott Laboratories Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.6.5 Abbott Laboratories Recent Development
11.7 Danaher Corporation
11.7.1 Danaher Corporation Company Detail
11.7.2 Danaher Corporation Business Overview
11.7.3 Danaher Corporation Point of Care & Rapid Diagnostics Introduction
11.7.4 Danaher Corporation Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.7.5 Danaher Corporation Recent Development
11.8 BD
11.8.1 BD Company Detail
11.8.2 BD Business Overview
11.8.3 BD Point of Care & Rapid Diagnostics Introduction
11.8.4 BD Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.8.5 BD Recent Development
11.9 Sysmex
11.9.1 Sysmex Company Detail
11.9.2 Sysmex Business Overview
11.9.3 Sysmex Point of Care & Rapid Diagnostics Introduction
11.9.4 Sysmex Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.9.5 Sysmex Recent Development
11.10 Cardinal Health
11.10.1 Cardinal Health Company Detail
11.10.2 Cardinal Health Business Overview
11.10.3 Cardinal Health Point of Care & Rapid Diagnostics Introduction
11.10.4 Cardinal Health Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.10.5 Cardinal Health Recent Development
11.11 Quidel
11.11.1 Quidel Company Detail
11.11.2 Quidel Business Overview
11.11.3 Quidel Point of Care & Rapid Diagnostics Introduction
11.11.4 Quidel Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.11.5 Quidel Recent Development
11.12 GE Healthcare
11.12.1 GE Healthcare Company Detail
11.12.2 GE Healthcare Business Overview
11.12.3 GE Healthcare Point of Care & Rapid Diagnostics Introduction
11.12.4 GE Healthcare Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.12.5 GE Healthcare Recent Development
11.13 EKF Diagnostics
11.13.1 EKF Diagnostics Company Detail
11.13.2 EKF Diagnostics Business Overview
11.13.3 EKF Diagnostics Point of Care & Rapid Diagnostics Introduction
11.13.4 EKF Diagnostics Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.13.5 EKF Diagnostics Recent Development
11.14 bioMérieux SA
11.14.1 bioMérieux SA Company Detail
11.14.2 bioMérieux SA Business Overview
11.14.3 bioMérieux SA Point of Care & Rapid Diagnostics Introduction
11.14.4 bioMérieux SA Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.14.5 bioMérieux SA Recent Development
11.15 Accubiotech
11.15.1 Accubiotech Company Detail
11.15.2 Accubiotech Business Overview
11.15.3 Accubiotech Point of Care & Rapid Diagnostics Introduction
11.15.4 Accubiotech Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.15.5 Accubiotech Recent Development
11.16 PTS Diagnostics
11.16.1 PTS Diagnostics Company Detail
11.16.2 PTS Diagnostics Business Overview
11.16.3 PTS Diagnostics Point of Care & Rapid Diagnostics Introduction
11.16.4 PTS Diagnostics Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.16.5 PTS Diagnostics Recent Development
11.17 Chembio Diagnostics
11.17.1 Chembio Diagnostics Company Detail
11.17.2 Chembio Diagnostics Business Overview
11.17.3 Chembio Diagnostics Point of Care & Rapid Diagnostics Introduction
11.17.4 Chembio Diagnostics Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.17.5 Chembio Diagnostics Recent Development
11.18 Trinity Biotech
11.18.1 Trinity Biotech Company Detail
11.18.2 Trinity Biotech Business Overview
11.18.3 Trinity Biotech Point of Care & Rapid Diagnostics Introduction
11.18.4 Trinity Biotech Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.18.5 Trinity Biotech Recent Development
11.19 Sekisui Diagnostics
11.19.1 Sekisui Diagnostics Company Detail
11.19.2 Sekisui Diagnostics Business Overview
11.19.3 Sekisui Diagnostics Point of Care & Rapid Diagnostics Introduction
11.19.4 Sekisui Diagnostics Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.19.5 Sekisui Diagnostics Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Point of Care & Rapid Diagnostics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Rapid Test
Table 3. Key Players of Molecular Diagnostics
Table 4. Global Point of Care & Rapid Diagnostics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Point of Care & Rapid Diagnostics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Point of Care & Rapid Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Point of Care & Rapid Diagnostics Market Share by Region (2018-2023)
Table 8. Global Point of Care & Rapid Diagnostics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Point of Care & Rapid Diagnostics Market Share by Region (2024-2029)
Table 10. Point of Care & Rapid Diagnostics Market Trends
Table 11. Point of Care & Rapid Diagnostics Market Drivers
Table 12. Point of Care & Rapid Diagnostics Market Challenges
Table 13. Point of Care & Rapid Diagnostics Market Restraints
Table 14. Global Point of Care & Rapid Diagnostics Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Point of Care & Rapid Diagnostics Market Share by Players (2018-2023)
Table 16. Global Top Point of Care & Rapid Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point of Care & Rapid Diagnostics as of 2022)
Table 17. Ranking of Global Top Point of Care & Rapid Diagnostics Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Point of Care & Rapid Diagnostics Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Point of Care & Rapid Diagnostics Product Solution and Service
Table 21. Date of Enter into Point of Care & Rapid Diagnostics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Point of Care & Rapid Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Point of Care & Rapid Diagnostics Revenue Market Share by Type (2018-2023)
Table 25. Global Point of Care & Rapid Diagnostics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Point of Care & Rapid Diagnostics Revenue Market Share by Type (2024-2029)
Table 27. Global Point of Care & Rapid Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Point of Care & Rapid Diagnostics Revenue Market Share by Application (2018-2023)
Table 29. Global Point of Care & Rapid Diagnostics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Point of Care & Rapid Diagnostics Revenue Market Share by Application (2024-2029)
Table 31. North America Point of Care & Rapid Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Point of Care & Rapid Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Point of Care & Rapid Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Point of Care & Rapid Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Point of Care & Rapid Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Point of Care & Rapid Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Point of Care & Rapid Diagnostics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Point of Care & Rapid Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Point of Care & Rapid Diagnostics Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Point of Care & Rapid Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Point of Care & Rapid Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Point of Care & Rapid Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Point of Care & Rapid Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Point of Care & Rapid Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Point of Care & Rapid Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 46. Johnson and Johnson Company Detail
Table 47. Johnson and Johnson Business Overview
Table 48. Johnson and Johnson Point of Care & Rapid Diagnostics Product
Table 49. Johnson and Johnson Revenue in Point of Care & Rapid Diagnostics Business (2018-2023) & (US$ Million)
Table 50. Johnson and Johnson Recent Development
Table 51. Thermo Fisher Scientific Company Detail
Table 52. Thermo Fisher Scientific Business Overview
Table 53. Thermo Fisher Scientific Point of Care & Rapid Diagnostics Product
Table 54. Thermo Fisher Scientific Revenue in Point of Care & Rapid Diagnostics Business (2018-2023) & (US$ Million)
Table 55. Thermo Fisher Scientific Recent Development
Table 56. Bio-Techne Company Detail
Table 57. Bio-Techne Business Overview
Table 58. Bio-Techne Point of Care & Rapid Diagnostics Product
Table 59. Bio-Techne Revenue in Point of Care & Rapid Diagnostics Business (2018-2023) & (US$ Million)
Table 60. Bio-Techne Recent Development
Table 61. Roche Diagnostics Company Detail
Table 62. Roche Diagnostics Business Overview
Table 63. Roche Diagnostics Point of Care & Rapid Diagnostics Product
Table 64. Roche Diagnostics Revenue in Point of Care & Rapid Diagnostics Business (2018-2023) & (US$ Million)
Table 65. Roche Diagnostics Recent Development
Table 66. Siemens Healthineers Company Detail
Table 67. Siemens Healthineers Business Overview
Table 68. Siemens Healthineers Point of Care & Rapid Diagnostics Product
Table 69. Siemens Healthineers Revenue in Point of Care & Rapid Diagnostics Business (2018-2023) & (US$ Million)
Table 70. Siemens Healthineers Recent Development
Table 71. Abbott Laboratories Company Detail
Table 72. Abbott Laboratories Business Overview
Table 73. Abbott Laboratories Point of Care & Rapid Diagnostics Product
Table 74. Abbott Laboratories Revenue in Point of Care & Rapid Diagnostics Business (2018-2023) & (US$ Million)
Table 75. Abbott Laboratories Recent Development
Table 76. Danaher Corporation Company Detail
Table 77. Danaher Corporation Business Overview
Table 78. Danaher Corporation Point of Care & Rapid Diagnostics Product
Table 79. Danaher Corporation Revenue in Point of Care & Rapid Diagnostics Business (2018-2023) & (US$ Million)
Table 80. Danaher Corporation Recent Development
Table 81. BD Company Detail
Table 82. BD Business Overview
Table 83. BD Point of Care & Rapid Diagnostics Product
Table 84. BD Revenue in Point of Care & Rapid Diagnostics Business (2018-2023) & (US$ Million)
Table 85. BD Recent Development
Table 86. Sysmex Company Detail
Table 87. Sysmex Business Overview
Table 88. Sysmex Point of Care & Rapid Diagnostics Product
Table 89. Sysmex Revenue in Point of Care & Rapid Diagnostics Business (2018-2023) & (US$ Million)
Table 90. Sysmex Recent Development
Table 91. Cardinal Health Company Detail
Table 92. Cardinal Health Business Overview
Table 93. Cardinal Health Point of Care & Rapid Diagnostics Product
Table 94. Cardinal Health Revenue in Point of Care & Rapid Diagnostics Business (2018-2023) & (US$ Million)
Table 95. Cardinal Health Recent Development
Table 96. Quidel Company Detail
Table 97. Quidel Business Overview
Table 98. Quidel Point of Care & Rapid Diagnostics Product
Table 99. Quidel Revenue in Point of Care & Rapid Diagnostics Business (2018-2023) & (US$ Million)
Table 100. Quidel Recent Development
Table 101. GE Healthcare Company Detail
Table 102. GE Healthcare Business Overview
Table 103. GE Healthcare Point of Care & Rapid Diagnostics Product
Table 104. GE Healthcare Revenue in Point of Care & Rapid Diagnostics Business (2018-2023) & (US$ Million)
Table 105. GE Healthcare Recent Development
Table 106. EKF Diagnostics Company Detail
Table 107. EKF Diagnostics Business Overview
Table 108. EKF Diagnostics Point of Care & Rapid Diagnostics Product
Table 109. EKF Diagnostics Revenue in Point of Care & Rapid Diagnostics Business (2018-2023) & (US$ Million)
Table 110. EKF Diagnostics Recent Development
Table 111. bioMérieux SA Company Detail
Table 112. bioMérieux SA Business Overview
Table 113. bioMérieux SA Point of Care & Rapid Diagnostics Product
Table 114. bioMérieux SA Revenue in Point of Care & Rapid Diagnostics Business (2018-2023) & (US$ Million)
Table 115. bioMérieux SA Recent Development
Table 116. Accubiotech Company Detail
Table 117. Accubiotech Business Overview
Table 118. Accubiotech Point of Care & Rapid Diagnostics Product
Table 119. Accubiotech Revenue in Point of Care & Rapid Diagnostics Business (2018-2023) & (US$ Million)
Table 120. Accubiotech Recent Development
Table 121. PTS Diagnostics Company Detail
Table 122. PTS Diagnostics Business Overview
Table 123. PTS Diagnostics Point of Care & Rapid Diagnostics Product
Table 124. PTS Diagnostics Revenue in Point of Care & Rapid Diagnostics Business (2018-2023) & (US$ Million)
Table 125. PTS Diagnostics Recent Development
Table 126. Chembio Diagnostics Company Detail
Table 127. Chembio Diagnostics Business Overview
Table 128. Chembio Diagnostics Point of Care & Rapid Diagnostics Product
Table 129. Chembio Diagnostics Revenue in Point of Care & Rapid Diagnostics Business (2018-2023) & (US$ Million)
Table 130. Chembio Diagnostics Recent Development
Table 131. Trinity Biotech Company Detail
Table 132. Trinity Biotech Business Overview
Table 133. Trinity Biotech Point of Care & Rapid Diagnostics Product
Table 134. Trinity Biotech Revenue in Point of Care & Rapid Diagnostics Business (2018-2023) & (US$ Million)
Table 135. Trinity Biotech Recent Development
Table 136. Sekisui Diagnostics Company Detail
Table 137. Sekisui Diagnostics Business Overview
Table 138. Sekisui Diagnostics Point of Care & Rapid Diagnostics Product
Table 139. Sekisui Diagnostics Revenue in Point of Care & Rapid Diagnostics Business (2018-2023) & (US$ Million)
Table 140. Sekisui Diagnostics Recent Development
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Point of Care & Rapid Diagnostics Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Point of Care & Rapid Diagnostics Market Share by Type: 2022 VS 2029
Figure 3. Rapid Test Features
Figure 4. Molecular Diagnostics Features
Figure 5. Global Point of Care & Rapid Diagnostics Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Point of Care & Rapid Diagnostics Market Share by Application: 2022 VS 2029
Figure 7. Hospital Case Studies
Figure 8. Home Care Case Studies
Figure 9. Point of Care & Rapid Diagnostics Report Years Considered
Figure 10. Global Point of Care & Rapid Diagnostics Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 11. Global Point of Care & Rapid Diagnostics Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Point of Care & Rapid Diagnostics Market Share by Region: 2022 VS 2029
Figure 13. Global Point of Care & Rapid Diagnostics Market Share by Players in 2022
Figure 14. Global Top Point of Care & Rapid Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point of Care & Rapid Diagnostics as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Point of Care & Rapid Diagnostics Revenue in 2022
Figure 16. North America Point of Care & Rapid Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 17. North America Point of Care & Rapid Diagnostics Market Share by Country (2018-2029)
Figure 18. United States Point of Care & Rapid Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. Canada Point of Care & Rapid Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Europe Point of Care & Rapid Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Point of Care & Rapid Diagnostics Market Share by Country (2018-2029)
Figure 22. Germany Point of Care & Rapid Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. France Point of Care & Rapid Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. U.K. Point of Care & Rapid Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Italy Point of Care & Rapid Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Russia Point of Care & Rapid Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Nordic Countries Point of Care & Rapid Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Asia-Pacific Point of Care & Rapid Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Point of Care & Rapid Diagnostics Market Share by Region (2018-2029)
Figure 30. China Point of Care & Rapid Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Japan Point of Care & Rapid Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. South Korea Point of Care & Rapid Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Southeast Asia Point of Care & Rapid Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. India Point of Care & Rapid Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Australia Point of Care & Rapid Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Latin America Point of Care & Rapid Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Point of Care & Rapid Diagnostics Market Share by Country (2018-2029)
Figure 38. Mexico Point of Care & Rapid Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Brazil Point of Care & Rapid Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Middle East & Africa Point of Care & Rapid Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Point of Care & Rapid Diagnostics Market Share by Country (2018-2029)
Figure 42. Turkey Point of Care & Rapid Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Saudi Arabia Point of Care & Rapid Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Johnson and Johnson Revenue Growth Rate in Point of Care & Rapid Diagnostics Business (2018-2023)
Figure 45. Thermo Fisher Scientific Revenue Growth Rate in Point of Care & Rapid Diagnostics Business (2018-2023)
Figure 46. Bio-Techne Revenue Growth Rate in Point of Care & Rapid Diagnostics Business (2018-2023)
Figure 47. Roche Diagnostics Revenue Growth Rate in Point of Care & Rapid Diagnostics Business (2018-2023)
Figure 48. Siemens Healthineers Revenue Growth Rate in Point of Care & Rapid Diagnostics Business (2018-2023)
Figure 49. Abbott Laboratories Revenue Growth Rate in Point of Care & Rapid Diagnostics Business (2018-2023)
Figure 50. Danaher Corporation Revenue Growth Rate in Point of Care & Rapid Diagnostics Business (2018-2023)
Figure 51. BD Revenue Growth Rate in Point of Care & Rapid Diagnostics Business (2018-2023)
Figure 52. Sysmex Revenue Growth Rate in Point of Care & Rapid Diagnostics Business (2018-2023)
Figure 53. Cardinal Health Revenue Growth Rate in Point of Care & Rapid Diagnostics Business (2018-2023)
Figure 54. Quidel Revenue Growth Rate in Point of Care & Rapid Diagnostics Business (2018-2023)
Figure 55. GE Healthcare Revenue Growth Rate in Point of Care & Rapid Diagnostics Business (2018-2023)
Figure 56. EKF Diagnostics Revenue Growth Rate in Point of Care & Rapid Diagnostics Business (2018-2023)
Figure 57. bioMérieux SA Revenue Growth Rate in Point of Care & Rapid Diagnostics Business (2018-2023)
Figure 58. Accubiotech Revenue Growth Rate in Point of Care & Rapid Diagnostics Business (2018-2023)
Figure 59. PTS Diagnostics Revenue Growth Rate in Point of Care & Rapid Diagnostics Business (2018-2023)
Figure 60. Chembio Diagnostics Revenue Growth Rate in Point of Care & Rapid Diagnostics Business (2018-2023)
Figure 61. Trinity Biotech Revenue Growth Rate in Point of Care & Rapid Diagnostics Business (2018-2023)
Figure 62. Sekisui Diagnostics Revenue Growth Rate in Point of Care & Rapid Diagnostics Business (2018-2023)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(QYR23MA7530 )"ポイントオブケア(POC)/迅速診断の世界市場2023年:迅速検査、分子診断" (英文:Global Point of Care & Rapid Diagnostics Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。